CA3084119A1 - Anticorps contre le facteur de croissance nerveuse anti-humain et methodes d'utilisation - Google Patents

Anticorps contre le facteur de croissance nerveuse anti-humain et methodes d'utilisation Download PDF

Info

Publication number
CA3084119A1
CA3084119A1 CA3084119A CA3084119A CA3084119A1 CA 3084119 A1 CA3084119 A1 CA 3084119A1 CA 3084119 A CA3084119 A CA 3084119A CA 3084119 A CA3084119 A CA 3084119A CA 3084119 A1 CA3084119 A1 CA 3084119A1
Authority
CA
Canada
Prior art keywords
antibody
seq
cdr
amino acid
chain variable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3084119A
Other languages
English (en)
Inventor
Zhu WANG
Yongjuan GAO
Cecily Rou-Yun Sun
Yuncheng ZHENG
Bill Nai-Chau Sun
Qiang Li
Si CHEN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ampsource Biopharma Shanghai Inc
Original Assignee
Ampsource Biopharma Shanghai Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ampsource Biopharma Shanghai Inc filed Critical Ampsource Biopharma Shanghai Inc
Priority to CA3084119A priority Critical patent/CA3084119A1/fr
Publication of CA3084119A1 publication Critical patent/CA3084119A1/fr
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
CA3084119A 2020-06-17 2020-06-17 Anticorps contre le facteur de croissance nerveuse anti-humain et methodes d'utilisation Pending CA3084119A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA3084119A CA3084119A1 (fr) 2020-06-17 2020-06-17 Anticorps contre le facteur de croissance nerveuse anti-humain et methodes d'utilisation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA3084119A CA3084119A1 (fr) 2020-06-17 2020-06-17 Anticorps contre le facteur de croissance nerveuse anti-humain et methodes d'utilisation

Publications (1)

Publication Number Publication Date
CA3084119A1 true CA3084119A1 (fr) 2021-12-17

Family

ID=78958244

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3084119A Pending CA3084119A1 (fr) 2020-06-17 2020-06-17 Anticorps contre le facteur de croissance nerveuse anti-humain et methodes d'utilisation

Country Status (1)

Country Link
CA (1) CA3084119A1 (fr)

Similar Documents

Publication Publication Date Title
JP6261499B2 (ja) Ｏｘ４０と結合する抗体およびその使用
CN114751982B (zh) 抗人ngf抗体及其制备方法和用途
AU2009243184B2 (en) Antibodies to granulocyte-macrophage colony-stimulating factor
KR102367723B1 (ko) 브라디키닌 b1 수용체 리간드에 대한 항체
AU2017250815A1 (en) Humanized anti-PACAP antibodies and uses thereof
CA2983030A1 (fr) Utilisation d'anticorps anti-pacap et de leurs fragments de liaison a l'antigene pour le traitement, la prevention ou l'inhibition de la photophobie
KR20230128134A (ko) Il-7r 알파 서브유닛에 대한 항체 및 이의 용도
US20140056918A1 (en) Oscar antagonists
US20190135912A1 (en) Interferon Alpha and Omega Antibody Antagonists
CN111683965A (zh) 用于治疗骨折或骨缺损的gremlin-1抑制剂
US11976115B2 (en) Antibody binding to human IL-1β, preparation method therefor and use thereof
AU2020204105B2 (en) Anti-human ngf antibodies and methods using same
US11655292B2 (en) Anti-human NGF antibodies and methods using same
CA3084119A1 (fr) Anticorps contre le facteur de croissance nerveuse anti-humain et methodes d'utilisation
WO2023125477A1 (fr) Anticorps trka et son application
JP2023538098A (ja) Ｆｇｆｒ３抗体および使用の方法
NZ619849B2 (en) Antibodies that bind to ox40 and their uses